AzTrials
AzTrials

LipedemaLipidExNCT05488977

The Effects of Endurance Training on Lipedema

A study testing Exercise training in people with Lipedema, run by Norwegian University of Science and Technology at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Lipedema is a fat disorder causing accumulation of subcutaneous adipose tissue particularly in arms and legs, and predominantly affects women. Lipedema likely contributes to an array of other pathologies, including obesity, inflammatory bowel disease, and neurological disorders. Read more about this study

Who is it for?
Ages 18 to 65 years, women only
Conditions the study is for
Lipedema
What is being tested?
Exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteNorway
Study dates
1 Jul 2022to 1 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • can meet for supervised exercise training in Trondheim.

Who cannot join

  • eating disorders and/or orthopedic limitations for exercise training

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Institute for Circulation and Medical Imaging, NTNU

    Trondheim

Other trials in Norway

About this study

Official title: The Effects of Endurance Training in Women With Lipedema

Lipedema is a fat disorder causing accumulation of subcutaneous adipose tissue particularly in arms and legs, and predominantly affects women. Lipedema likely contributes to an array of other pathologies, including obesity, inflammatory bowel disease, and neurological disorders. Lipedema tissue is often very painful and can severely impair mobility. The condition can also increase the incidence of depression, anxiety, or eating disorders.

There seems to be a general impression that lipedema tissue is difficult to reduce by diet, exercise, or bariatric surgery. However, only a few studies have actually explored the effects of exercise training on lipedema. Despite the lack of knowledge, the existing guidelines for lipidemia treatment promote a healthy lifestyle with individually adjusted weight control measures, including physical activity. In general, exercise is known to have an important effect on adipose tissue. Excess adipose tissue causes macrophage infiltration into the adipose tissue leading to continuous low systemic inflammation. This would suggest that there is a systemic inflammatory response in lipedema patients. Increasing IL-6 levels with exercise can decrease the level of proinflammatory TNFalpha synthesized from adipocytes and therefore lead to an anti-inflammatory effect by increasing IL-10 and IL-1ra levels. IL-6 also stimulates fat oxidation by increasing lipolysis. For these reasons, adding an appropriate exercise program to standard treatment might provide additional benefits for lipedema patients. The investigators aim to determine the therapeutic potential of high-intensity interval training (HIIT) on pain, quality of life, body composition, cardiorespiratory fitness and circulating biomarkers in women with lipedema.

Read the detailed description

Methods

Subjects 30 women diagnosed with lipedema age 18-65 will be randomized to (1:1) to 8 weeks of exercise training og a control group. Exclusion criteria includes ongoing eating disorders and/or orthopedic limitations for exercise training. A compliance with the training program of 80% will also be set as a criterion for completing the study. Participants will be recruited via social media, via physiotherapists, via posters at GPs and via a user representative from the Norwegian Lymphedema and Lipedema Association (NLLF). The master's students will obtain informed consent cf. GCP and the Health Research Act. The potential participants will have at least one week to consider their participation. If a research participant should be injured on the basis of something the investigators ask them to do, NTNU will have the insurance responsibility. The investigators will collect data on the type and stage of lipedema, when the participant was diagnosed. The investigators will also collect data on which clinical aids they are using and how often, e.g., compressions aids.

Intervention - Training protocol The women will be randomized (1:1) to 8 weeks of supervised high-intensity interval training (HIIT) that is 4×4 min intervals at 85-95% of maximal heart rate (HRmax) with 3-minute active breaks (~60 % HRmax) in between intervals, twice a week) on treadmills at the NextMove core facility at NTNU or to a control group. All participants will be provided with a pulse watch to keep after the study is completed. In addition, the participants will perform exercise once a week on their own following the correct exercise intensity. Pool training will be recommended based on potential benefits from compression. Body composition, blood pressure, VO2max (maximal oxygen uptake), questionnaire data and blood samples will be measured/collected before and after the exercise intervention. The participants will write a diary for their physical activity using standardized templates from the NextMove core facility.

Maximal oxygen uptake (VO2max) VO2max will be measured during uphill treadmill walking or running (Woodway PPS 55 Med, Munich, Germany), using ergospirometry (Jaeger, Oxycon pro, Hoechberg, Germany / Meta Max II, Cortex, Leipzig, Germany) as described earlier.11 A warm-up period for 10 min (~60% of HRmax) will precede the test. A levelling off of oxygen uptake (VO2) despite increased work load and respiratory exchange ratio ≥1.05 will be used as criteria for VO2max. HR will be measured continuously during the test (Polar, Polar Electro, Kempele, Finland), to define HRmax.

Anthropometric measurements Body weight, body mass index and waist-to-hip ratio will be measured. Body composition will be measured using InBody. For measurement of body composition, the investigators will use an instrument called Inbody 720 (Body Analysis AS). Inbody 720 provides weight, muscle mass, fat percentage, metabolism and mineral status non-invasively by sending weak electrical signals through the body. The whole test lasts just a few minutes. Before the analysis the participants should be fasten at least two hours and should avoid strenuous exercise. The standard procedures at NextMove will be used to measure the weight and height of participants. The height will be measured without shoes or head wear, this must be done with equal weight on both legs. The distance between the legs shall be a foot. The heels should be in the ground at full stretch their legs. The height is measured with one decimal. The weight is measured without heavy clothes and shoes, while the participants are standing still. It will be drawn 0.5 kg for the remaining clothes. The weight is measured with one decimal. The participants must stand upright for measuring of waist and hip circumference and a regular exhaust measuring the circumference one cm over the navel. The waist circumference is measured with no decimals.

Blood pressure Blood pressure will be measured while the patient is sitting down and have been resting for at least five minutes in a quiet room. It will be measured by a trained person, with a handheld sphygmomanometer (Tycos, 5098-02CB, USA). Blood pressure will be measured at the same time of the day for each individual at pre- and post test. The first reading will be discarded and the mean of the next three consecutive readings with a coefficient of variation below 15% will be used in the study, with additional readings if required. The sleeve should be placed at heart level and customized with the size of the participants arm.

Pain and fatigue registration Visual analog scale (VAS), measured by means of a 0-100 mm, for pain will be used to collect data on pain. VAS has been used in the social and behavioral sciences to measure a variety of subjective phenomena. A VAS is a straight line, whose end anchors indicate the extreme boundaries of the sensation, feeling, or responses to be measured. For example a VAS to measure pain can be labeled "no pain" on one end and "pain as bad as it could possibly be" on the other end. Subjects respond to the VAS by placing a mark through the line at a position which best represents their current perception of a given phenomenon between the labeled extremes. Although a VAS may be horizontal or vertical and of any length deemed appropriate, its most common form is a 100 mm horizontal line. The VAS is scored by measuring the distance, usually in millimeters, from one end of the scale to the subject's mark on the line. In the present study, a score from 1-100 was used for measuring self reported total pain and fatigue. LYMQOL (Lymphoedema Quality of Life) BEN and Brief Pain Inventory will be applied.

Quality of life questionnaires Short Form Health Survey-36 (SF-36) will be used to track potential changes in quality of life. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The eight sections are; vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health.

Standard blood analyses Blood collection and blood analyses will be performed using standard local procedures for the general biomarkers in clinical use and will be performed in all participants at the pre- and post-test. Three 3ml EDTA-tubes and one 3ml Li-heparin-tube will be collected and sent to clinical-chemical analyses at St.Olav's hospital. Parameters to be analyzed includes e.g. glucose, HbA1C, triglycerides, HDL-cholesterol, total cholesterol, serum ferritin and hs-CRP. An additional two tubes of blood (serum and EDTA) will be collected for later explorative biomarker assays. These blood samples will be centrifuged and aliquoted before freezing and storing in the LipidEx-biobank. A test from the standard laboratory that is without normal range may indicate a need for following up by a doctor, will be reported back to the participant as soon as possible, thus they will be asked to contact their general practitioner. The participants must fast at least three-hours before blood sampling. The time of last meal time for participants will be recorded on the patient form.

ELISA for lipedema biomarkers The ELISA technique can detect an amount of a given protein, antibody, or antigen in a sample. Explorative biomarkers outside clinical use will be assayd by ELISA methods established at the local laboratories at the Department of Circulation and Medical imaging. Potential biomarkers include TNFalpha, interleukines as well as PF4/CXCL4.

NMR Lipidomics/metabolomics/inflammatomics To explore the beneficial effects of HIIT on blood profile in these individuals, NMR (nuclear magnetic resonance) technology will be applied to determine if changes occur on the 1) lipoprotein subfractions that cannot be detected by measuring standard lipids, 2) changes occur in the metabolome and 3) changes occur in the inflammatory status. Lipidomics is a recently developed research area that apply different techniques to perform large-scale analyses of circulating lipids. NMR lipidomics utilizes differences in lipoprotein composition, size and density to extract information on lipoprotein subclasses. Several studies have demonstrated an association between lipoprotein subfractions and future cardiovascular health. This suggest that more refined analyses of lipoprotein subfractions may lead to further improvements in monitoring cardiovascular health. Lipidomics technology has developed rapidly over the past decade, to the point where clinical application now is possible.

Statistical power This is a pilot study, as there is very limited knowledge on exercise as treatment for lipedema. That is, no variables are available for power calculations. The investigators have chosen to set the number to 15 in each group to be able to account for up to 20% drop-outs. With the limited time available during a Master's project, this is a realistic target.

Data protection Patient information will be stored and handled in conformity with Norwegian laws and regulations.

Conditions
Lipedema
Being tested
Exercise training
Medical subject headings
Lipedema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise trainingBehavioural

    8 weeks of supervised high-intensity interval training (HIIT).

Study groups in NCT05488977
Study groupRoleWhat they receive
Exercise trainingExperimental8 weeks of supervised high-intensity interval training (HIIT) that is 4×4 min intervals at 85-95% of maximal heart rate (HRmax) with 3-minute active breaks (~60 % HRmax) in between intervals, twice a week) on treadmills. In addition, the participants will perform exercise once a week on their own following the correct exercise intensity.
Receives: Behavioral: Exercise training
ControlNo interventionNo intervention. Carry on their normal life.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analog scale (VAS)

    Visual analog scale (VAS), measured by means of a 0-100 mm, for pain will be used to collect data on pain. VAS has been used in the social and behavioral sciences to measure a variety of subjective phenomena. A VAS is a straight line, whose end anchors indicate the extreme boundaries of the sensation, feeling, or responses to be measured. For example, a VAS to measure pain can be labeled "no pain" on one end and "pain as bad as it could possibly be" on the other end. Subjects respond to the VAS by placing a mark through the line at a position which best represents their current perception of a given phenomenon between the labeled extremes. Although a VAS may be horizontal or vertical and of any length deemed appropriate, its most common form is a 100 mm horizontal line. The VAS is scored by measuring the distance, usually in millimeters, from one end of the scale to the subject's mark on the line.

    Measured: Change from baseline to 8 weeks

Secondary outcomes (21)
  1. LYMQOL (Lymphoedema Quality of Life) legs

    Self-reported questionnaire reporting quality of life adapted to lipedema patients.

    This questionnaire has been designed and validated for patients with chronic oedema/ lymphoedema of one or both legs to measure quality of life. The patients will tick the box that best describes how they feel about each of the questions.The questionaire includes 22 main questions. The patient may tick one of the following; "Not at all", "A little", "Quite a bit" or "A lot". The last question includes a scale. The title of the scale is "Overall, how would you rate your quality of life at present?". The minimum value is 0 and mean Poor, whereas the maximum value is 10 and means Excellent.

    Measured: Change from baseline to 8 weeks

  2. Brief Pain Inventory

    Self-reported questionnaire reporting pain. The Brief Pain Inventory is a validated, widely used, self-administered questionnaire developed to assess the severity of pain and the impact of pain on daily functions. The title of the scale is pain. The BPI scale defines pain as follows:

    Worst Pain Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain.

    Measured: Change from baseline to 8 weeks

  3. Short Form Health Survey-36 (SF-36)

    Self-reported questionnaire reporting quality of life. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

    Measured: Change from baseline to 8 weeks

  4. Glucose

    Serum levels of glucose

    Measured: Change from baseline to 8 weeks

  5. HbA1C

    Serum levels of HbA1C

    Measured: Change from baseline to 8 weeks

  6. Triglycerides

    Serum levels of triglycerides

    Measured: Change from baseline to 8 weeks

  7. HDL-cholesterol

    Serum levels of HDL-cholesterol

    Measured: Change from baseline to 8 weeks

  8. Total cholesterol

    Serum levels of total cholesterol

    Measured: Change from baseline to 8 weeks

  9. Ferritin

    Serum levels of ferritin

    Measured: Change from baseline to 8 weeks

  10. hs-CRP

    Serum levels of hs-CRP

    Measured: Change from baseline to 8 weeks

  11. Interleukin

    Serum levels of interleukin

    Measured: Change from baseline to 8 weeks

  12. PF4/CXCL4

    Serum levels of PF4/CXCL4

    Measured: Change from baseline to 8 weeks

  13. TNFalpha

    Serum levels of TNFalpha

    Measured: Change from baseline to 8 weeks

  14. Protein levels in blood

    Aprox. 200 proteins will be quantified (mmol/l) in blood by nuclear magnetic resonance.

    Measured: Change from baseline to 8 weeks

  15. Systolic blood pressure

    Systolic blood pressure

    Measured: Change from baseline to 8 weeks

  16. Diastolic blood pressure

    Diastolic blood pressure

    Measured: Change from baseline to 8 weeks

  17. Body weight

    Body weight based on InBody 720

    Measured: Change from baseline to 8 weeks

  18. Muscle mass

    Total muscle mass and in different parts of the body based on InBody 720

    Measured: Change from baseline to 8 weeks

  19. Fat percentage

    Total fat percentage and in different parts of the body based on InBody 720

    Measured: Change from baseline to 8 weeks

  20. Resting metabolism

    Whole body resting metabolism based on InBody 720

    Measured: Change from baseline to 8 weeks

  21. Maximal oxygen uptake

    VO2max will be measured during uphill treadmill walking or running (Woodway PPS 55 Med, Munich, Germany), using ergospirometry (Jaeger, Oxycon pro, Hoechberg, Germany / Meta Max II, Cortex, Leipzig, Germany)

    Measured: Change from baseline to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2022
  2. Study start1 Jul 2022
  3. Primary completion1 Feb 2025
  4. Study completion1 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05488977
Sponsor's protocol ID
461077
Acronym
LipidEx
Status last verified
Jun 2025
First submitted
8 Jul 2022
Last updated
10 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training in people with Lipedema, run by Norwegian University of Science and Technology at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analog scale (VAS) (time frame: Change from baseline to 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in